AKT1 and cancer: The link between high NFE2L2 expression in cancer cells and the tumorigenesis process itself seems to involve oncogenic pathways, such as MAPK-ERK and PI3K-AKT-mTOR, whose aberrant activation has been strongly associated with the activity of NRF2 [33,34].